Skip to content

Kayne Anderson BDC KBDC Net regulatory assets

Net regulatory assets at other companies

BGC Group, Inc. logo
BGC Group, Inc.BGC
$925M+21.1%
Southern Company logo
Southern CompanySO
$4.71B-14.2%
OGS
ONE GASOGS
-$149.14M+22.2%
Kayne Anderson BDC logo
Kayne Anderson BDCKBDC
$1.08M-8.3%
OGS
ONE GASOGS
-$188.99M-0.2%
OGS
ONE GASOGS
$39.85M+1,374%

Other financials

Income statement

See full
Operating income-$28.4M-7.3%
Net income$17.2M-22.4%
EPS (diluted)$0.43+7.5%

Balance sheet

See full
Cash & equivalents$14.3M-17.6%
Total debt$1.3B
Total equity$1.1B-8.3%
Total assets$2.3B+1.0%

Cash flow

See full
Operating cash flow$39.8M+131%

Valuation

See full
Market cap$905.68M-19.5%
P/E10.2×+1.3×

Returns & leverage

See full
Return on equity7.9%-4.8pp
Debt / equity2.1×

Where this comes from

Reported directly by Kayne Anderson BDC in its filing.

Tagged under the XBRL concept us-gaap:NetRegulatoryAssets.

The official record: Kayne Anderson BDC’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kayne Anderson BDC's net regulatory assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kayne Anderson BDC's net regulatory assets?
Kayne Anderson BDC (KBDC) reported net regulatory assets of $1.08M in Q1 2026.
How has Kayne Anderson BDC's net regulatory assets changed year-over-year?
Kayne Anderson BDC's net regulatory assets decreased by 8.3% year-over-year, from $1.18M to $1.08M.
What is the long-term trend for Kayne Anderson BDC's net regulatory assets?
Over 4 years (2021 to 2025), Kayne Anderson BDC's net regulatory assets has grown at a 37.3% compound annual growth rate (CAGR), from $311.97M to $1.11B.
What does net regulatory assets mean?
Represents the total value of assets adjusted for specific regulatory requirements or constraints imposed on the business development company. This metric helps investors understand the portion of the balance sheet that is effectively available for investment or subject to regulatory leverage limits. It is a critical indicator of the company's capacity to deploy capital while remaining in compliance with statutory mandates.